313 related articles for article (PubMed ID: 11257229)
1. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
[TBL] [Abstract][Full Text] [Related]
2. Crystallization and preliminary X-ray analyses of quaternary, ternary and binary protein-DNA complexes with involvement of AML1/Runx-1/CBFalpha Runt domain, CBFbeta and the C/EBPbeta bZip region.
Tahirov TH; Inoue-Bungo T; Sasaki M; Shiina M; Kimura K; Sato K; Kumasaka T; Yamamoto M; Kamiya N; Ogata K
Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):850-3. PubMed ID: 11375505
[TBL] [Abstract][Full Text] [Related]
3. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
4. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha.
Tang YY; Shi J; Zhang L; Davis A; Bravo J; Warren AJ; Speck NA; Bushweller JH
J Biol Chem; 2000 Dec; 275(50):39579-88. PubMed ID: 10984496
[TBL] [Abstract][Full Text] [Related]
5. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.
Tang YY; Crute BE; Kelley JJ; Huang X; Yan J; Shi J; Hartman KL; Laue TM; Speck NA; Bushweller JH
FEBS Lett; 2000 Mar; 470(2):167-72. PubMed ID: 10734228
[TBL] [Abstract][Full Text] [Related]
6. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
[TBL] [Abstract][Full Text] [Related]
7. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
Nagata T; Werner MH
J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation.
Li Z; Lukasik SM; Liu Y; Grembecka J; Bielnicka I; Bushweller JH; Speck NA
J Mol Biol; 2006 Dec; 364(5):1073-83. PubMed ID: 17059830
[TBL] [Abstract][Full Text] [Related]
9. Structure and backbone dynamics of Apo-CBFbeta in solution.
Wolf-Watz M; Grundström T; Härd T
Biochemistry; 2001 Sep; 40(38):11423-32. PubMed ID: 11560490
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta.
Warren AJ; Bravo J; Williams RL; Rabbitts TH
EMBO J; 2000 Jun; 19(12):3004-15. PubMed ID: 10856244
[TBL] [Abstract][Full Text] [Related]
11. Cooperative binding of DNA and CBFbeta to the Runt domain of the CBFalpha studied via MD simulations.
Habtemariam B; Anisimov VM; MacKerell AD
Nucleic Acids Res; 2005; 33(13):4212-22. PubMed ID: 16049027
[TBL] [Abstract][Full Text] [Related]
12. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
Bravo J; Li Z; Speck NA; Warren AJ
Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
[TBL] [Abstract][Full Text] [Related]
13. Solution properties of the free and DNA-bound Runt domain of AML1.
Wolf-Watz M; Xie XQ; Holm M; Grundström T; Härd T
Eur J Biochem; 1999 Apr; 261(1):251-60. PubMed ID: 10103057
[TBL] [Abstract][Full Text] [Related]
14. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts.
Kurokawa M; Tanaka T; Tanaka K; Hirano N; Ogawa S; Mitani K; Yazaki Y; Hirai H
J Biol Chem; 1996 Jul; 271(28):16870-6. PubMed ID: 8663420
[TBL] [Abstract][Full Text] [Related]
15. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
Zhang L; Li Z; Yan J; Pradhan P; Corpora T; Cheney MD; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33097-104. PubMed ID: 12807883
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
18. Energetic contribution of residues in the Runx1 Runt domain to DNA binding.
Li Z; Yan J; Matheny CJ; Corpora T; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33088-96. PubMed ID: 12807882
[TBL] [Abstract][Full Text] [Related]
19. Chloride binding by the AML1/Runx1 transcription factor studied by NMR.
Wolf-Watz M; Bäckström S; Grundström T; Sauer U; Härd T
FEBS Lett; 2001 Jan; 488(1-2):81-4. PubMed ID: 11163800
[TBL] [Abstract][Full Text] [Related]
20. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).
Gu TL; Goetz TL; Graves BJ; Speck NA
Mol Cell Biol; 2000 Jan; 20(1):91-103. PubMed ID: 10594012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
